Tag: Patients
Search News
Broadening cancer gene testing
21st July 2020
Screening entire populations for breast and ovarian cancer gene mutations could prevent millions more cancer cases across the world compared to current clinical practice, according to an international study led by Queen Mary University of London.
Read more
Covid-19 and blood cancer
3rd June 2020
One of the first studies to investigate the outcome of Covid-19 infection in patients with blood cancer has been conducted by clinical researchers from Barts Cancer Institute, Queen Mary University of London, and Barts Health NHS Trust.
Read more
Immunotherapy for advanced bladder cancer
29th May 2020
An immunotherapy drug called ‘avelumab’ has been shown to significantly improve survival in patients with the most common type of bladder cancer, according to results from a phase III clinical trial led by Professor Tom Powles.
Read more
Personalised ovarian cancer risk prediction reduces worries
18th May 2020
Offering personalised ovarian cancer risk prediction to women shows that 98 per cent of participants felt less worried after finding out their ovarian cancer risk status, according to a new study.
Read more
Metal analysis of urine for pancreatic cancer detection
28th April 2020
Research has revealed that the signature of metal ions present in urine samples is an accurate indicator of pancreatic ductal adenocarcinoma, one of the deadliest types of cancer.
Read more
New and valuable insights into familial myeloid leukaemia
3rd March 2020
Research has identified new genetic features implicated in a type of blood cancer known as familial myeloid leukaemia. The study, published in Nature Communications, offers novel insights into the biology of this inherited cancer, and provides a framework to inform how to more effectively manage at-risk individuals and patients affected by this type of blood malignancy.
Read more